Search

Sort by:
Results 24351 - 24360 of 36112 for Tumors
  • Piolitazone shows promise for preventing brain injury from radiation therapy
    News - 10 Jan 2007
    Researchers at Wake Forest University School of Medicine are the first to report that in animal studies, a common diabetes drug prevents the memory and learning problems that cancer patients often...
  • Ryogen licenses gene patent to Invitrogen
    News - 9 Jan 2007
    Ryogen LLC announced today that the company have entered into a nonexclusive license agreement with Invitrogen Corporation, whereby Invitrogen has licensed from Ryogen the patent directed to the...
  • Nanotechnology continues to advance anticancer gene therapy
    News - 20 Nov 2006
    Given that cancer is a disease in which genetic errors play a major role, it should come as no surprise that many experts envision a time when gene therapy will play an equally important role in the...
  • FDA expands use of Herceptin
    News - 19 Nov 2006
    The U.S. Food and Drug Administration (FDA) has expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the...
  • External-beam radiation therapy safe for breast cancer
    News - 8 Nov 2006
    External-beam radiation therapy for early-stage breast cancer can be delivered safely and in a shorter course that eliminates as much as two weeks from conventional treatment.
  • PSA blood tests for prostate cancer should start earlier in life
    News - 2 Nov 2006
    A study has found that measuring prostate specific antigen (PSA) in the blood may be the best way of identifying men with life-threatening prostate cancer.
  • Teen's radiation overdose down to paperwork
    News - 30 Oct 2006
    A report into the death of a teenage cancer patient who was given, in error, massive overdoses of radiation to treat a brain tumour, was apparently down to paperwork.
  • GSK seeks regulatory approval in U.S., Europe for Tykerb
    News - 20 Sep 2006
    GlaxoSmithKline on Monday said it has submitted its experimental breast cancer drug Tykerb, which is taken orally, for FDA approval and plans to file for approval in Europe in the fourth quarter of...
  • Vitamin D cuts the risk of pancreatic cancer
    News - 12 Sep 2006
    Consumption of Vitamin D tablets was found to cut the risk of pancreatic cancer nearly in half, according to a study led by researchers at Northwestern and Harvard universities.
  • Ryogen licenses gene patent to OriGene Technologies
    News - 15 Aug 2006
    Ryogen and OriGene Technologies have announced today that they have entered into a nonexclusive license agreement whereby OriGene has licensed from Ryogen the patent directed to the clinically...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback